About this trial
The study investigates taste disorders that commonly occur during or after cancer treatment, often leading to issues such as malnutrition and treatment discontinuation. Although many non-pharmacological recommendations exist, it is unclear which methods are suitable for which individuals. This pilot study aims to use an AI-based, or rule-driven system to generate personalized recommendations based on patients' specific impairments and taste disorder. For the pilot study, the AI will be trained on recipes to create individualized meal plans, helping to identify foods that are likely to be better. The primary endpoint is the assessment of the nutritional intervention as helpful at the second visit within 12 weeks of inclusion.
Eligibility criteria
Qualifiers
Age ≥ 18
Suffering from one of the following tumor entities: Multiple myeloma or malignant tumor of the gastrointestinal tract
Mainly oral nutrition
Subjectively perceived tumor therapy-related taste disorder
Disqualifiers
Pregnancy
Taste disorder explained by other causes (e.g. existing before therapy or COVID disease)
Placement in an inpatient care facility
Trial design
Treatments tested in this trial
- Gustabor server
Treatment groups
Sponsors and collaborators
Wuerzburg University Hospital
Lead sponsor
LMU Klinikum
Collaborator
University Hospital Regensburg
Collaborator